Oncology Subspecialist for Phase 1–2 Trials & Research Time

American Society of Clinical Oncology (ASCO); Peoria (IL); On-site; USD 585,000 - 715,000; Full time

Benefits offered by this job

Relocation assistance

CME allowance

PTO

Significant research time potential

Job summary

ASCO is launching a groundbreaking regional oncology program in Peoria, IL, spanning 25 oncologists and backed by philanthropic investment and a partnership with the University of Illinois system. The role supports Medical Oncology or Hematology/Oncology with subspecialization options and offers potential for up to 40% research time in Phase 1 & 2 trials.

New $250 million cancer center with EPIC EMR, generous benefits, and autonomy to shape the practice, with 3–4 clinic days per week and

Qualifications

• Medical Oncology or Hematology/Oncology with ability to subspecialize exclusively in GI, Lung, GU, Malignant Hematology, Breast, or Head & Neck.
• Become a key contributor to Phase 1 & 2 clinical trials, with potential for up to 40% research time.
• Optional academic faculty appointment, access to basic science lab, and partnering with University of Illinois system.

Responsibilities

• Lead and contribute to Phase 1 & 2 trials across subspecialties with cross-disciplinary collaboration.
• Build and shape a flexible practice with autonomy; 3–4 clinic days per week.
• Engage in academic collaborations and teaching opportunities as available.

Skills

Medical Oncology

Hematology/Oncology

Clinical trials

Job description

ASCO is launching a groundbreaking regional oncology program in Peoria, IL, spanning 25 oncologists and backed by philanthropic investment and a partnership with the University of Illinois system. The role supports Medical Oncology or Hematology/Oncology with subspecialization options and offers potential for up to 40% research time in Phase 1 & 2 trials.

New $250 million cancer center with EPIC EMR, generous benefits, and autonomy to shape the practice, with 3–4 clinic days per week and